Nuclear Medicine: Page 311

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

December 14, 2008

Aposense begins trial

By AuntMinnie.com staff writers

Molecular imaging and therapy developer Aposense has begun a phase II trial of its apoptosis molecular imaging agent.

December 14, 2008

Siemens gets FDA OK for IQ-SPECT

By AuntMinnie.com staff writers

Siemens Healthcare has received clearance from the U.S. Food and Drug Administration for IQ-SPECT.

December 14, 2008

Nuclear myocardial perfusion imaging: Vulnerable to self-referral?

By Kate Madden Yee

Nuclear myocardial perfusion imaging (MPI) can be a powerful tool against heart disease, but the procedure is costly. Researchers are investigating how MPI is used -- and by whom -- to evaluate whether overuse of the technology contributes to inflated healthcare costs.

December 14, 2008

IBA responds to FDA warning letter

By AuntMinnie.com staff writers

Radiopharmaceutical firm Ion Beam Applications (IBA) has responded to a warning letter from the U.S. Food and Drug Administration related to manufacturing practices for PET radiotracers at a facility in Virginia.

December 10, 2008

PET SUV measurements vary between facilities

By Eric Barnes

For lung cancer patients undergoing chemotherapy and radiation, PET can be a good way to monitor and even predict treatment response. But the response measured in standardized uptake values (SUVs) can vary significantly depending on the facility in which SUV is measured.

December 9, 2008

GE, Orbotech dispute goes to arbitration

By AuntMinnie.com staff writers

Israeli electronics industry technology firm Orbotech said that GE Healthcare and its subsidiary GE Healthcare Systems Israel are referring a dispute between the firms to arbitration.

December 8, 2008

Neoprobe completes financing

By AuntMinnie.com staff writers

Gamma camera probe developer Neoprobe has wrapped up a $3 million investment in convertible preferred stock and warrants by Platinum-Montaur Life Sciences (Montaur).

December 7, 2008

Breast-specific gamma imaging reveals unseen cancers

By Edward Susman

CHICAGO - A review of clinical use of breast-specific gamma imaging shows that the function-based technology changed breast cancer treatment options because additional malignancies were pinpointed by the new modality, according to research presented at this week's RSNA conference.

December 3, 2008

PEM may reduce false-positive reports

By Edward Susman

CHICAGO - Research from Florida suggests that diagnosing suspected breast cancer with positron emission mammography (PEM) has the potential to reduce false positives when compared to MRI.

December 2, 2008

IBA opens production center in Dallas

By AuntMinnie.com staff writers

Radiopharmaceutical firm Ion Beam Applications (IBA) is opening a new PET radiopharmaceutical production facility in Dallas, the company announced.

December 1, 2008

IBA signs deal with Biotech Cyclotron

By AuntMinnie.com staff writers

Radiopharmaceutical firm Ion Beam Applications (IBA) announced that it has signed a cooperative agreement with Biotech Cyclotron of Texas for the delivery of PET compounds and the sale of two of its facilities.

November 30, 2008

Previous Page

Page 311 of 440

Next Page